About Medi-Globe Group
Medi-Globe Group is a company based in Rohrdorf (Germany) founded in 1990 was acquired by DCC in September 2022. Medi-Globe Group offers products and services including Endoscopic Devices, Urological Instruments, and Pulmonology Devices. Medi-Globe Group operates in a competitive market with competitors including Orphalan, NIMBLE Diagnostics, OneroRx, Nutrasource and Droplet, among others.
- Headquarter Rohrdorf, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medi-Globe Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medi-Globe Group
Medi-Globe Group offers a comprehensive portfolio of products and services, including Endoscopic Devices, Urological Instruments, and Pulmonology Devices.
Innovative tools for gastroenterological minimally invasive procedures
Equipment for minimally invasive urology treatments and diagnostics
Flexible devices for pulmonological diagnosis and interventions
Funding Insights of Medi-Globe Group
Detailed funding history for Medi-Globe Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Medi-Globe Group
Medi-Globe Group has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include DCC and Duke Street.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in Europe are managed by Duke Street.
|
Locked | Locked | Locked | |
|
International sales, marketing, and support services are provided globally.
|
Locked | Locked | Locked |
Investor details for Medi-Globe Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medi-Globe Group
Investment portfolio details for Medi-Globe Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medi-Globe Group
Detailed financials for Medi-Globe Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medi-Globe Group Comparisons
Peer comparison for Medi-Globe Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medi-Globe Group
Medi-Globe Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orphalan, NIMBLE Diagnostics, OneroRx, Nutrasource and Droplet, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer and provider of access to innovative treatments to patients with rare diseases
|
|
| Locked | Locked | Locked |
Non-invasive diagnostic devices for cardiovascular stent monitoring are developed.
|
|
| Locked | Locked | Locked |
Telepharmacy services are delivered via an online platform for consultations.
|
|
| Locked | Locked | Locked |
Marketing services are provided for healthcare, nutraceutical, and pharmaceutical sectors.
|
|
| Locked | Locked | Locked |
Home pathology samples are collected and diagnostic tests are provided.
|
Detailed competitors of Medi-Globe Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medi-Globe Group
Complete news archive for Medi-Globe Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medi-Globe Group
Medi-Globe Group was founded in 1990.
Medi-Globe Group is headquartered in Rohrdorf, Germany. It is registered at Rohrdorf, Bavaria, Germany.
Martin Lehner is the current CEO of Medi-Globe Group.
Medi-Globe Group was established in 1990 in Rohrdorf, Germany, within the medical devices sector. Focus is placed on the development and marketing of diagnostic and therapeutic solutions for healthcare applications. Operations are centered in Europe, with products distributed to support clinical procedures worldwide. Leadership is provided by CEO Martin Lehner, ensuring alignment with industry standards and regulatory requirements.
Medi-Globe Group's top competitors include Droplet, Orphalan and PharmaReview.
Medi-Globe Group offers Endoscopic Devices, Urological Instruments, and Pulmonology Devices.
Medi-Globe Group has 2 investors. Key investors include DCC, and Duke Street.